All Stories

  1. Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?

    Article • Drug Safety, December 2014, Springer Science + Business Media

    Barbara Osimani

  2. Causing something to be one way rather than another

    Article • Kybernetes, May 2014, Emerald

    Barbara Osimani

  3. Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methods

    Article • Preventive Medicine Reports, January 2014, Elsevier

    Barbara Osimani

  4. Hunting Side Effects and Explaining Them: Should We Reverse Evidence Hierarchies Upside Down?

    Article • Topoi, October 2013, Springer Science + Business Media

    Barbara Osimani

  5. Until RCT proven? On the asymmetry of evidence requirements for risk assessment

    Article • Journal of Evaluation in Clinical Practice, May 2013, Wiley

    Barbara Osimani

  6. The precautionary principle in the pharmaceutical domain: a philosophical enquiry into probabilistic reasoning and risk aversion

    Article • Health Risk & Society, April 2013, Taylor & Francis

    Barbara Osimani

  7. Risk information processing and rational ignoring in the health context

    Article • The Journal of Socio-Economics, April 2012, Elsevier

    Barbara Osimani

  8. Disability, Human Rights, and the International Classification of Functioning, Disability, and Health

    Article • American Journal of Physical Medicine & Rehabilitation, February 2012, Wolters Kluwer Health

    Barbara Osimani

  9. Revision of International Classification of Functioning, Disability and Health Ethical Guidelines

    Article • American Journal of Physical Medicine & Rehabilitation, February 2012, Wolters Kluwer Health

    Barbara Osimani

  10. Scientific Evidence and the Law

    Article • The Journal of Philosophy Science & Law, January 2011, Philosophy Documentation Center

    Barbara Osimani

  11. Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management

    Article • Health Risk & Society, October 2010, Taylor & Francis

    Barbara Osimani